Navigation Links
Boston Scientific to Participate in Morgan Stanley Conference
Date:4/24/2008

NATICK, Mass., April 24 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Morgan Stanley Global Healthcare Unplugged Conference, which is being held April 30 - May 2 in Miami.

On Wednesday, April 30, at 9:50 a.m. ET, Paul LaViolette, Chief Operating Officer of Boston Scientific, will present a five-minute overview of the Company, followed by a 35-minute question and answer session.

A live webcast of Mr. LaViolette's remarks will be available to all interested parties at Boston Scientific's website at http://www.bostonscientific.com. To ensure a timely connection to the webcast it is recommended that users register at least 15 minutes before the webcast begins.

This webcast is being hosted by Morgan Stanley. The replay will be archived and available in the Investor Relations site at http://www.bostonscientific.com.

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: http://www.bostonscientific.com.

CONTACT: Larry Neumann

508-650-8696

Investor Relations

Boston Scientific Corporation

Paul Donovan

508-650-8541

Media Relations

Boston Scientific Corporation


'/>"/>
SOURCE Boston Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Boston Scientific Completes Enrollment in Landmark Heart Failure Trial
2. Boston Scientific Named Healthcare Supplier of the Year by Global Healthcare Exchange (GHX)
3. Philips Supports the Boston Marathon as the Sole Provider of Life-Saving Medical Devices
4. DARA Announces Surgi-Vision Agreement with Boston Scientific Corporation
5. Boston Trial to Test New HIV/AIDS Vaccine
6. Boston College biologists build a better mouse model for cancer research
7. Every Boston Red Sox Home Run Televised on NESN in 2008 to Help Children With Medical Needs
8. Boston Scientific Announces Appointment of Timothy Pratt as General Counsel
9. Boston Kids Enjoy Free Davis Vision Screenings
10. Boston Medical Center Meets Prescription Challenges With Kryptiq ePrescribing Solution
11. Transcept Pharmaceuticals to Present at Cowen and Companys 27th Annual Health Care Conference in Boston
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... , ... Harris Communications, Inc., a leading provider of assistive technology for ... Deaf Seniors of America Conference, April 4-7 at the Hotel Westin Galleria in Houston. ... staff from Harris Communications and to try out the newest assistive devices available to ...
(Date:3/25/2017)... ... , ... Getting earned media coverage meaningful for Garden Media Group's clients is ... year, Garden Media aims to provide material helpful to clients’ goals and bottom lines. ... key messages to gain coveted media placements, Garden Media wows clients year-round. , ...
(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... ... solutions for contaminated soil, dredged material, and hazardous and non-hazardous materials announced today ... Allentown, Pennsylvania. This acquisition will add four additional processing facilities and a ...
(Date:3/24/2017)... ... March 24, 2017 , ... Mediaplanet today ... conversation on the current obstacles facing infection prevention and offer strategies for the ... by these infections. , The print component of “Fighting Infection” is distributed ...
(Date:3/24/2017)... ... March 24, 2017 , ... Digital Scientists, a software innovation lab specializing in ... a Greenville, South Carolina location. The lab has set up shop at ... been working with South Carolina clients for years from our office here in Atlanta,” ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... and BOSTON , March 27, ... global pharmaceutical company and Paratek Pharmaceuticals, Inc. (Nasdaq: ... and commercialization of innovative therapies based upon tetracycline ... of sarecycline for the treatment of moderate to ... endpoints. Sarecycline is a once-daily, oral, narrow spectrum ...
(Date:3/27/2017)... 27, 2017  PhaseRx, Inc. (NASDAQ: PZRX), a ... liver diseases in children, today reported financial results ... December 31, 2016 and provided an update on ... to make progress during the fourth quarter of ... our non-human primate safety study, and with our lead ...
(Date:3/24/2017)... , Mar 24, 2017 Research ... Therapy Manufacturing Market, 2017-2027" report to their offering. ... The Cell ... the rapidly growing market of cell therapy manufacturing and focuses ... manufacturing facilities. These therapies are anticipated to emerge as viable ...
Breaking Medicine Technology: